Message: Return type of CI_Session_null_driver::open($save_path, $name) should either be compatible with SessionHandlerInterface::open(string $path, string $name): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::close() should either be compatible with SessionHandlerInterface::close(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::read($session_id) should either be compatible with SessionHandlerInterface::read(string $id): string|false, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::write($session_id, $session_data) should either be compatible with SessionHandlerInterface::write(string $id, string $data): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::destroy($session_id) should either be compatible with SessionHandlerInterface::destroy(string $id): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::gc($maxlifetime) should either be compatible with SessionHandlerInterface::gc(int $max_lifetime): int|false, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
NRIPage | Articles | Torrent Pharmaceuticals to Hold Meeting for Interim Dividend on Jan. 24 | Get Indian Desi Latest Political News & Updates in USA. Get domestic, republic government updates - NRI Page
Torrent Pharmaceuticals Ltd. will hold a meeting on January 24 to consider the payment of an interim dividend for the financial year 2024-25. The company has set February 1 as the record date for determining the eligible members for the dividend payment, if declared. The interim dividend will be for the equity shares of Rs 5 each.
Earlier, Samir Mehta, President of the Indian Pharmaceutical Alliance and Chairperson of Torrent Group, highlighted the industry's plans to grow significantly, aiming for a size of $120–130 billion by 2030, powered by innovation and leadership in global healthcare. Mehta emphasized India's strength in producing high-quality generic drugs and vaccines, positioning the country as a prominent global player.
Despite a 1.38% drop in shares during the day, Torrent Pharmaceuticals' stock price has increased by 30.71% over the past year, with 19 out of 32 analysts tracking the stock recommending a 'buy.'
